Immunomodulatory properties of cacao extracts - potential consequences for medical applications

Frontiers in Pharmacology

Volumn 4 DEC, Issue , 2013, Pages

  Becker, Kathrin ^a   Geisler, Simon ^a   Ueberall, Florian ^a   Fuchs, Dietmar ^a   Gostner, Johanna M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anti inflammatory; Cacao; Cocoa; Immunology; Neurobiochemistry; Tryptophan metabolism

Indexed keywords

ALPHA INTERFERON; CACAO EXTRACT; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2; KYNURENINE; NEOPTERIN; PLANT EXTRACT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; CACAO; CELL PROTECTION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; DEPRESSION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; MOOD DISORDER; NEUROPROTECTION; NONHUMAN; REVIEW; SEROTONIN METABOLISM; TRYPTOPHAN METABOLISM;

EID: 84891670149     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00154     Document Type: Review

References (84)

1. Adams, S., Braidy, N., Bessede, A., Brew, B. J., Grant, R., Teo, C., et al. (2012). The kynurenine pathway in brain tumor pathogenesis. Cancer Res. 72, 5649-5657. doi: 10.1158/0008-5472.CAN-12-0549.
2. Aggarwal, B. B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208. doi: 10.1016/j.ccr.2004.09.003.
3. Albarracin, S. L., Stab, B., Casas, Z., Sutachan, J. J., Samudio, I., Gonzalez, J., et al. (2012). Effects of natural antioxidants in neurodegenerative disease. Nutr. Neurosci. 15, 1-9 doi: 10.1179/1476830511Y.0000000028.
4. Andert, S. E., Griesmacher, A., Zuckermann, A., and Müller, M. M. (1992). Neopterin release from human endothelial cells is triggered by interferon-gamma. Clin. Exp. Immunol. 88, 555-558. doi: 10.1111/j.1365-2249.1992.tb06486.x.
5. Asehnoune, K., Strassheim, D., Mitra, S., Kim, J. Y., and Abraham, E. (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172, 2522-2529.
6. Balakrishnan, K., and Adams, L. E. (1995). The role of the lymphocyte in an immune response. Immunol. Invest. 24, 233-244. doi: 10.3109/08820139509062775.
7. Barth, H., Berg, P. A., and Klein, R. (2003). Methods for the in vitro determination of an individual disposition towards TH1-or TH2-reactivity by the application of appropriate stimulatory antigens. Clin. Exp. Immunol. 134, 78-85. doi: 10.1046/j.1365-2249.2003.02265.
8. Bisson, J. F., Nejdi, A., Rozan, P., Hidalgo, S., Lalonde, R., Messaoudi, M., et al. (2008). Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats. Br. J. Nutr. 100, 94-101. doi: 10.1017/S0007114507886375.
9. Bowler, R. P., and Crapo, J. D. (2002). Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol. 110, 349-356. doi: 10.1067/mai.2002.126780.
10. Bravo, L. (1998). Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56, 317-33 doi: 10.1111/j.1753-4887.1998.tb01670.x.
11. Brigelius-Flohé, R., Kluth, D., and Banning, A. (2005). Is there a future for antioxidants in atherogenesis? Mol. Nutr. Food Res. 49, 1083-1089. doi: 10.1002/mnfr.200500094.
12. Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., et al. (2003). Interferon-alpha-induced changes in tryptophan metabolism, relationship to depression and paroxetine treatment. Mol. Psychiatry 9, 906-914. doi: 10.1016/S0006-3223(03)00173-2.
13. Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., and Dantzer, R. (2002). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 5, 468-473. doi: 10.1038/sj.mp.4000995.
14. Capuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., et al. (2011). Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol. Psychiatry 70, 175-82 doi: 10.1016/j.biopsych.2010.12.006.
15. Cirillo, P., Pacileo, M., DE Rosa, S., Calabrò, P., Gargiulo, A., Angri, V., et al. (2006). Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells. J. Thromb. Haemost. 4, 2248-2255 doi: 10.1111/j.1538-7836.2006.02125.x.
16. Corti, R., Flammer, A. J., Hollenberg, N. K., and Lüscher, T. F. (2009). Cocoa and cardiovascular health. Circulation 119, 1433-1441. doi: 10.1161/CIRCULATIONAHA.108.827022.
17. Dantzer, R., and Kelley, K. W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 21, 153-160. doi: 10.1016/j.bbi.2006.09.006.
18. DeVane, C. L. (1998). Differential pharmacology of newer antidepressants. J. Clin. Psychiatry 20, 85-93.
19. Engler, M. B., Engler, M. M., Chen, C. Y., Malloy, M. J., Browne, A., Chiu, E. Y., et al. (2004). Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr. 23, 197-204. doi: 10.1080/07315724.2004.10719361.
20. Fisher, N. D., Hughes, M., Gerhard-Herman, M., and Hollenberg, N. K. (2003). Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J. Hypertens. 21, 2281-2286. doi: 10.1097/00004872-200312000-00016.
21. Fuchs, D., Hausen, A., Huber, C., Margreiter, R., Reibnegger, G., Spielberger, M., et al. (1982). Pteridine secretion as a marker for the proliferation of alloantigen-induced lymphocytes. Hoppe Seylers Z. Physiol. Chem. 363, 661-664.
22. Fuchs, D., Möller, A. A., Reibnegger, G., Stöckle, E., Werner, E. R., and Wachter, H. (1990). Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J. Acquir. Immune Defic. Syndr. 3, 873-876.
23. Fuchs, D., Weiss, G., Reibnegger, G., and Wachter, H. (1992). The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit. Rev. Clin. Lab. Sci. 29, 307-341. doi: 10.3109/10408369209114604.
24. Galleano, M., Oteiza, P. I., and Fraga, C. G. (2009). Cocoa, chocolate, and cardiovascular disease. J. Cardiovasc. Pharmacol. 54, 483-490. doi: 10.1097/FJC.0b013e3181b76787.
25. Gershon, M. D., and Tack, J. (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414. doi: 10.1053/j.gastro.2006.11.002.
26. Grammer, T. B., Fuchs, D., Boehm, B. O., Winkelmann, B. R., and Maerz, W. (2009). Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen risk and cardiovascular health study. Clin. Chem. 55, 1135-1146. doi: 10.1373/clinchem.2008.118844.
27. Grassi, D., Desideri, G., and Ferri, C. (2010). Blood pressure and cardiovascular risk: what about cocoa and chocolate? Arch. Biochem. Biophys. 501, 112-115. doi: 10.1016/j.abb.2010.05.020.
28. Heiss, C., Dejam, A., Kleinbongard, P., Schewe, T., Sies, H., and Kelm, M. (2003). Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030-1031. doi: 10.1001/jama.290.8.1030.
29. Heyes, M. P., Saito, K., Crowley, J. S., Davis, L. E., Demitrack, M. A., Der, M., et al. (1992). Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115, 1249-1273. doi: 10.1093/brain/115.5.1249.
30. Hoekstra, R., Fekkes, D., van de Wetering, B. J., Pepplinkhuizen, L., and Verhoeven, W. M. (2003). Effect of light therapy on biopterin, neopterin and tryptophan in patients with seasonal affective disorder. Psychiatry Res. 120, 37-42 doi: 10.1016/S0165-1781(03)00167-7.
31. Hofmann, B., Bass, H., Nishanian, P., Faisal, M., Figlin, R. A., Sarna, G. P., et al. (1992). Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. Clin. Exp. Immunol. 88, 548-554. doi: 10.1111/j.1365-2249.1992.tb06485.x.
32. Hronek, M., Zadak, Z., Solichova, D., Jandik, P., and Melichar, B. (2000). The association between specific nutritional antioxidants and manifestation of colorectal cancer. Nutrition 16, 189-191. doi: 10.1016/S0899-9007(99)00285-3.
33. Hurst, W. J., Tarka, S. M. Jr., Powis, T. G., Valdez, F. Jr., and Hester, T. R. (2002). Cacao usage by the earliest Maya civilization. Nature 418, 289-290. doi: 10.1038/418289a.
34. Jenny, M., Klieber, M., Zaknun, D., Schroecksnadel, S., Kurz, K., Ledochowski, M., et al. (2011). In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm. Res. 60, 127-135. doi: 10.1007/s00011-010-0244-y.
35. Jenny, M., Santer, E., Klein, A., Ledochowski, M., Schennach, H., Ueberall, F., et al. (2009). Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells. J. Ethnopharmacol. 122, 261-267 doi: 10.1016/j.jep.2009.01.011.
36. Jin, B., Sun, T., Yu, X. H., Yang, Y. X., and Yeo, A. E. (2012). The effects of TLR activation on T-cell development and differentiation. Clin. Dev. Immunol. 2012:836485. doi: 10.1155/2012/836485.
37. Joshipura, K. J., Hu, F. B., Manson, J. E., Stampfer, M. J., Rimm, E. B., Speizer, F. E., et al. (2001). The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med. 12, 1106-1114. doi: 10.7326/0003-4819-134-12-200106190-00010.
38. Keen, C. L., Holt, R. R., Oteiza, P. I., Fraga, C. G., and Schmitz, H. H. (2005). Cocoa antioxidants and cardiovascular health. Am. J. Clin. Nutr. 81, 298-303.
39. Klein, C., Patte-Mensah, C., Taleb, O., Bourguignon, J. J., Schmitt, M., Bihel, F., et al. (2013). The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Neuropharmacology 70, 254-260. doi: 10.1016/j.neuropharm.2013.02.006.
40. Lucey, D. R., Clerici, M., and Shearer, G. M. (1996). Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9, 532-562.
41. Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., et al. (1994). Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res. 2,143-160. doi: 10.1016/0165-1781(94)90003-5.
42. Miller, K. B., Stuart, D. A., Smith, N. L., Lee, C. Y., McHale, N. L., Flanagan, J. A., et al. (2006). Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J. Agric. Food Chem. 54, 4062-4068. doi: 10.1021/jf060290o.
43. Mullen, W., Borges, G., Donovan, J. L., Edwards, C. A., Serafini, M., Lean, M. E., et al. (2009). Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am. J. Clin. Nutr. 89, 1784-1791. doi: 10.3945/ajcn.2008.27339.
44. Murr, C., Fuith, L. C., Widner, B., Wirleitner, B., Baier-Bitterlich, G., and Fuchs, D. (1999). Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 19, 1721-1728.
45. Murr, C., Widner, B., Sperner-Unterweger, B., Ledochowski, M., Schubert, C., and Fuchs, D. (2000). Immune reaction links disease progression in cancer patients with depression. Med. Hypotheses 2, 137-140. doi: 10.1054/mehy.1999.1043.
46. Murr, C., Widner, B., Wirleitner, B., and Fuchs, D. (2002). Neopterin as a marker for immune system activation. Curr. Drug Metab. 3, 175-187. doi: 10.2174/1389200024605082.
47. Murr, C., Winklhofer-Roob, B. M., Schroecksnadel, K., Maritschnegg, M., Mangge, H., Bohm, B. et al. (2009). Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 202, 543-549. doi: 10.1016/j.atherosclerosis.2008.04.047.
48. Nathan, C. F. (1986). Peroxide and pteridine: a hypothesis on the regulation of macrophage antimicrobial activity by interferon-gamma. Interferon 7, 125-143.
49. Neurauter, G., Schroecksnadel, K., Scholl-Bürg,i S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., et al. (2008). Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr. Drug Metab. 9, 622-627. doi: 10.2174/138920008785821738.
50. Parker, G., Parker, I., and Brotchie, H. (2006). Mood state effects of chocolate. J. Affect. Disord. 92, 149-159. doi: 10.1016/j.jad.2006.02.007.
51. Payne, M. J., Hurst, W. J., Miller, K. B., Rank, C., and Stuart, D. A. (2010). Impact of fermentation, drying, roasting, and Dutch processing on epicatechin and catechin content of cacao beans and cocoa ingredients. J. Agric. Food Chem. 58, 10518-10527. doi: 10.1021/jf102391q.
52. Pedersen, E. R., Midttun, Ø., Ueland, P. M., Schartum-Hansen, H., Seifert, R., Igland, J., et al. (2011). Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 31,698-704. doi: 10.1161/ATVBAHA.110.219329.
53. Pfefferkorn, E. R. (1986). Interferon-gamma and the growth of Toxoplasma gondii in fibroblasts. Ann. Inst. Pasteur. Microbiol. 137A, 348-352. doi: 10.1016/S0769-2609(86)80047-3.
54. Ramiro, E., Franch, A., Castellote, C., Pérez-Cano, F., Permanyer, J., Izquierdo-Pulido, M., et al. (2005). Flavonoids from Theobroma cacao down-regulate inflammatory mediators. J. Agric. Food Chem. 53, 8506-8511. doi: 10.1021/jf0511042.
55. Ramsey, S. A., Gold, E. S., Aderem, A. (2010). A systems biology approach to understanding atherosclerosis. EMBO Mol. Med. 2, 79-89. doi: 10.1002/emmm.201000063.
56. Rein, D., Paglieroni, T. G., Wun, T., Pearson, D. A., Schmitz, H. H., Gosselin, R., et al. (2000). Cocoa inhibits platelet activation and function. Am. J. Clin. Nutr. 72, 30-35.
57. Rios, L. Y., Bennett, R. N., Lazarus, S. A., Rémésy, C., Scalbert, A., and Williamson, G. (2002). Cocoa procyanidins are stable during gastric transit in humans. Am. J. Clin. Nutr. 76, 1106-1110.
58. Rodríguez-Ramiro, I., Ramos, S., Bravo, L., Goya, L., and Martín, M. á. (2011). Procyanidin B2 and a cacao polyphenolic extract inhibit acrylamide-induced apoptosis in human Caco-2 cells by preventing oxidative stress and activation of JNK pathway. J. Nutr. Biochem. 22, 1186-1194. doi: 10.1016/j.jnutbio.2010.10.005.
59. Romagnani, S. (2004). Immunologic influences on allergy and the TH1/TH2 balance. J. Allergy Clin. Immunol. 113, 395-400. doi: 10.1016/j.jaci.2003.11.025.
60. Romagnani, S. (2006). Regulation of the T cell response. Clin. Exp. Allergy 36, 1357-1366. doi: 10.1111/j.1365-2222.2006.02606.x.
61. Rusconi, M., and Conti, A. (2010). Theobroma cacao L., the Food of the Gods: a scientific approach beyond myths and claims. Pharmacol. Res. 61, 5-13. doi: 10.1016/j.phrs.2009.08.008.
62. Sas, K., Robotka, H., Toldi, J., and Vécsei, L. (2007). Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J. Neurol. Sci. 257, 221-239 doi: 10.1016/j.jns.2007.01.033.
63. Schroecksnadel, K., Fischer, B., Schennach, H., Weiss, G., and Fuchs, D. (2007). Antioxidants suppress Th1-type immune response in vitro. Drug Metab. Lett. 1, 166-171 doi: 10.2174/187231207781369816.
64. Schroecksnadel, K., Frick, B., Winkler, C., and Fuchs, D. (2006a). Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr. Vasc. Pharmacol. 4, 205-213. doi: 10.2174/157016106777698379.
65. Schröcksnadel, K., Wirleitner, B., Winkler, C., and Fuchs, D. (2006b). Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim. Acta 364, 82-90. doi: 10.1016/j.cca.2005.06.013.
66. Serafini, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S., and Crozier, A. (2003). Plasma antioxidants from chocolate. Nature 424:1013. doi: 10.1038/4241013a.
67. Solà, R., Valls, R. M., Godàs, G., Perez-Busquets, G., Ribalta, J., Girona, J., et al. (2012). Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial. PLoS ONE 7:31103. doi: 10.1371/journal.pone.0031103.
68. Spadafranca, A., Martinez, Conesa, C., Sirini, S., and Testolin, G. (2010). Effect of dark chocolate on plasma epicatechin levels, DNA resistance to oxidative stress and total antioxidant activity in healthy subjects. Br. J. Nutr. 103, 1008-1014. doi: 10.1017/S0007114509992698.
69. Stevenson, D. E., and Hurst, R. D. (2007). Polyphenolic phytochemicals-just antioxidants or much more? Cell. Mol. Life Sci. 64, 2900-2916. doi: 10.1007/s00018-007-7237-1.
70. Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3,768-780. doi: 10.1038/nrc1189.
71. van Dam, R. M., Naidoo, N., and Landberg, R. (2013). Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol. 24, 25-33. doi: 10.1097/MOL.0b013e32835bcdff.
72. van de Vijver, L. P., Kardinaal, A. F., Grobbee, D. E., Princen, H. M., and van Poppel, G. (1997). Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence. Prostaglandins Leukot. Essent. Fatty Acids 57, 479-487. doi: 10.1016/S0952-3278(97)90432-4.
73. Weiss, G., Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Werner-Felmayer, G., et al. (1993). Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett. 321, 89-92. doi: 10.1016/0014-5793(93)80627-7.
74. Weiss, G., Schwaighofer, H., Herold, M., Nachbaur, D., Wachter, H., Niederwieser, D., et al. (1995). Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation. Transplantation 60, 1239-1244.
75. Werner, E. R., Bichler, A., Daxenbichler, G., Fuchs, D., Fuith, L. C., Hausen, A., et al. (1987). Determination of neopterin in serum and urine. Clin. Chem. 33, 62-66.
76. Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G., and Wachter, H. (1989). Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem. J. 262, 861-866.
77. Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G., Yim, J. J., et al. (1990). Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. J. Biol. Chem. 265, 3189-3192.
78. Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M., and Fuchs, D. (2002). Neopterin production, tryptophan degradation, and mental depression-what is the link? Brain Behav. Immun. 16, 590-595. doi: 10.1016/S0889-1591(02)00006-5.
79. Widner, B., Wirleitner, B., Baier-Bitterlich, G., Weiss, G., and Fuchs, D. (2000). Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Arch. Immunol. Ther. Exp. (Warsz) 48, 251-258.
80. Williams, C. D. (2013). Antioxidants and prevention of gastrointestinal cancers. Curr. Opin. Gastroenterol. 2, 195-200. doi: 10.1097/MOG.0b013e32835c9d1b.
81. Winkler, C., Wirleitner, B., Schroecksnadel, K., Schennach, H., and Fuchs, D. (2004). St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro. Biol. Chem. 385, 1197-1202. doi: 10.1515/BC.2004.155.
82. Zaknun, D., Schroecksnadel, S., Kurz, K., and Fuchs, D. (2012). Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma. Int. Arch. Allergy Immunol. 157,113-124. doi: 10.1159/000329137.
83. Zeng, H., Locatelli, M., Bardelli, C., Amoruso, A., Coisson, J. D., Travaglia, F., et al. (2011). Anti-inflammatory properties of clovamide and Theobroma cacao phenolic extracts in human monocytes: evaluation of respiratory burst, cytokine release, NF-κB activation, and PPARγ modulation. J. Agric. Food Chem. 59, 5342-5350. doi: 10.1021/jf2005386.
84. Zvetkova, E., Wirleitner, B., Tram, N. T., Schennach, H., and Fuchs, D. (2001). Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Int. Immunopharmacol. 1, 2143-2150. doi: 10.1016/S1567-5769(01)00140-0.